In the last
post on the Roche-Cipla judgment, I had given a brief primer on the facts
and timelines. I intend to continue the discussion in a few posts discussing
the various issues dealt with in what must be the most-awaited patent decision
in India in recent times, besides the compulsory licensing order in the Bayer-NATCO
case.
Before I proceed to discuss the judgment,
what is important to note is that for a suit which was instituted in January
2008, the final verdict has been pronounced in September 2012, which for me is
an achievement in itself. Considering the speed with which other matters are
generally decided, it is encouraging to note that a patent trial was concluded
in 4 years.
Although some might say this is still slow
considering the expedition with which IP matters are dealt with outside the
country, I prefer to take an optimistic view of the decision at least in this
respect. If 4 years were to be taken as a benchmark for conclusion of patent
matters, it is certainly not a bad time frame considering how our Courts
function. Now, to the merits of the case.
From Para 28 on, the issue of patent validity
has been dealt with. 9 grounds of challenge were raised by Cipla against the
patent IN196744. From internal Page 24-48 of the judgment, the rival contentions
of both parties with respect to obviousness have been captured. Para 30 on, the
ground of obviousness has been discussed. The Learned Single Judge gives his views on
the various grounds of revocation from Para 36 on.
The first issue the Court has dealt with is
lack of inventive step. The standard that is to be applied to understand as to
who would qualify as a person skilled in the art in order to evaluate the
inventiveness of the invention appears to have engaged the Court quite a bit.
The Court observed that before applying US or UK tests, “it is necessary to discuss
the patent law governing in India in form of Patents Act 1970 in order to find
out the true test on the basis of which the obviousness or inventive step in
the patent is required to be tested”.
The discussion of the Court on the definition
of “inventive step” is not entirely accurate in my opinion. In Paras 41, 42 and
43, the Court has observed the following on the basis of Section 2(1)(ja) and
Section 64:
“41. On the bare reading of the
aforementioned Sections, it is clear that the definition of inventive step
nowhere accords any differential treatment to any particular type of invention.
Rather, it lays down the general test which is indicative towards technological
advancement and the non obviousness of an invention to a person skilled in art.
Besides the same, the said definition of inventive step u/s 2(ja) which has
been newly inserted in the Patents Act (Amendment) 2005 once read with grounds
of revocation u/s 64 nowhere indicate any special treatment or different tests
to be applied for any particular type of invention more specifically medicinal,
chemical, industrial, etc.
42. On conjoint reading of the Section 64
read with Section 2(ja), it is clearly discernible that there are certain
essential ingredients of Section 2(ja) in order to call any invention to
qualify the threshold of inventive step. The said ingredients are:-
a) That the said invention involves a
technical advancement as compared to existing knowledge or economic
significance or both; and
b) That makes the invention non obvious to
the persons skilled in art
43. These
are conjunctive requirements u/s 2(ja) which means that not merely there should
be a technical advancement in the invention but at the same time, it should not
be obvious to the person skilled in art. Therefore, both the requirements are
to be satisfied conjunctively. It is noteworthy here again that beyond the said
two ingredients, there is no further ingredient which should be read into in
order to enlarge or limit the scope of the Section. ”
The
underscored portion above is a matter of concern because to me it appears the
Court has limited the definition of “inventive step” to the presence of a “technical
advancement which is not obvious to a person skilled in the art”. This is a misreading
of the section and it has the effect of abridging its scope. I had discussed
the same issue in an earlier post titled “Inventive
Step Under the Patents Act, 1970: Where is the Confusion?” In that post,
the following is what I said:
“The abridged and
incorrect interpretation of the definition is that inventive step is equated to
“a non-obvious technical advance”. This, however, has no basis in the wording
of the definition or the legislative policy that is reflected in the definition.
Therefore,
on the interpretation of the definition of inventive step, I disagree with the
Hon’ble Court because in my humble opinion is the Court has unduly curtailed the
scope of the definition to only technical advancement. In the next post, I will
continue with the Court’s discussion on inventive step.
No comments:
Post a Comment